Chandelier
发表于 2025-3-28 16:09:36
http://reply.papertrans.cn/19/1891/189028/189028_41.png
Ejaculate
发表于 2025-3-28 21:42:03
http://reply.papertrans.cn/19/1891/189028/189028_42.png
fluffy
发表于 2025-3-29 01:15:16
Transurethral Resection of Bladder Tumors (TURBT)surgery has been shown to have a significant impact on oncologic outcome. Imaging techniques such as blue light cystoscopy have been proven to further improve detection rates and oncologic outcomes. The impact of en bloc resection on recurrence and progression rates is currently under investigation.
Stress-Fracture
发表于 2025-3-29 04:58:08
http://reply.papertrans.cn/19/1891/189028/189028_44.png
LUMEN
发表于 2025-3-29 09:00:32
http://reply.papertrans.cn/19/1891/189028/189028_45.png
东西
发表于 2025-3-29 15:09:19
Adjuvant Intravesical Chemotherapy. 68:7–30, 2018) About 75% of these newly diagnosed cases are nonmuscle-invasive bladder cancer (NMIBC). With such a large percentage of all bladder cancer patients having nonmuscle-invasive disease at diagnosis, it is fitting that the American Urological Association has a guideline specifically add
gospel
发表于 2025-3-29 16:08:16
Device-Assisted Therapies for Nonmuscle-Invasive Bladder Cancer: A Practical Approach(NMIBC) or in the case of limited supply of conventional drugs. Device-assisted therapy can be done with hyperthermia or an electrical current. Based on (limited) published literature and personal experience, three methods of device-assisted therapy, which are currently mostly used in clinical trial
不开心
发表于 2025-3-29 22:42:58
Intravesical Salvage Therapy After BCG/Regular Chemoy is the mainstay of frontline therapy; however, recurrence will still occur for 40–80% of patients over a 10-year period. Radical cystectomy with urinary diversion remains the standard of care for many of these patients; however, recent evidence suggests that this is underutilized as many patients
exhibit
发表于 2025-3-30 01:49:48
Oncological Monitoring of NonMuscle Invasive Bladder Cancer (NMIBC) cancer (NMIBC) comprises the majority of these cases and is known for its varying oncological outcomes and need for frequent follow-up and treatment. However, there is significant heterogeneity between surveillance protocols and an undefined role for the implementation of new endoscopic technology
Amenable
发表于 2025-3-30 06:54:36
http://reply.papertrans.cn/19/1891/189028/189028_50.png